DGICB vs WST · P/E 10, rev $978.0M vs P/E 35, rev $1.72B
Donegal Group B Inc (DGICB) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Donegal Group B Inc (DGICB) is a insurance - property & casualty company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported DGICB revenue for 2025-12-31 was $978.0M. Net income was $79.3M. Revenue was down 1.2% from 2024-12-31 to 2025-12-31. DGICB currently screens at market cap $677.6M and trailing P/E 10.3.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
DGICB currently screens at market cap $677.6M and trailing P/E 10.3. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the DGICB and WST stock pages for the full models.
Not investment advice.